BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stremmel W, Weiskirchen R. Therapeutic strategies in Wilson disease: pathophysiology and mode of action. Annals Trans Med. 2021;. [PMID: 33987430 DOI: 10.21037/atm-20-3090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Daniel-robin T, Bénichou B, Leboucher C, Blein C, Combal J. Epidemiology, treatment and burden of Wilson Disease in France: a 10-year analysis of the National Health Insurance Database. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101992] [Reference Citation Analysis]
2 Stremmel W, Longerich T, Liere R, Vacata V, van Helden J, Weiskirchen R. Wilson disease — the impact of hyperimmunity on disease activity: A case report. World J Clin Cases 2021; 9(6): 1386-1393 [PMID: 33644206 DOI: 10.12998/wjcc.v9.i6.1386] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular Mechanisms of Liver Fibrosis. Front Pharmacol 2021;12:671640. [PMID: 34025430 DOI: 10.3389/fphar.2021.671640] [Reference Citation Analysis]
4 Lynch EN, Campani C, Innocenti T, Dragoni G, Forte P, Galli A. Practical insights into chronic management of hepatic Wilson’s disease. World J Clin Cases 2022; 10(14): 4334-4347 [DOI: 10.12998/wjcc.v10.i14.4334] [Reference Citation Analysis]